Literature DB >> 16127271

Treatment adherence rates one year after initiation of a systematic hospital-based stroke prevention program.

Bruce Ovbiagele1, Chelsea S Kidwell, Scott Selco, Tannaz Razinia, Jeffrey L Saver.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 16127271     DOI： 10.1159/000087711

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN： 1015-9770            Impact factor:   2.762


× No keyword cloud information.
  8 in total

1.  Secondary preventive medication persistence and adherence 1 year after stroke.

Authors:  C D Bushnell; D M Olson; X Zhao; W Pan; L O Zimmer; L B Goldstein; M J Alberts; S C Fagan; G C Fonarow; S C Johnston; C Kidwell; K A Labresh; B Ovbiagele; L Schwamm; E D Peterson
Journal:  Neurology       Date:  2011-09-07       Impact factor: 9.910

2.  Tackling the growing diabetes burden in Sub-Saharan Africa: a framework for enhancing outcomes in stroke patients.

Authors:  Bruce Ovbiagele
Journal:  J Neurol Sci       Date:  2014-11-26       Impact factor: 3.181

3.  Tailored Hospital-based Risk Reduction to Impede Vascular Events After Stroke (THRIVES) study: qualitative phase protocol.

Authors:  Mayowa O Owolabi; Rufus O Akinyemi; Samantha Hurst; Oyedunni Arulogun; Olanrewaju Olaniyan; Mulugeta Gebregziabher; Babatunde L Salako; Bruce Ovbiagele
Journal:  Crit Pathw Cardiol       Date:  2014-03

Review 4.  A new model for secondary prevention of stroke: transition coaching for stroke.

Authors:  Cheryl Bushnell; Martinson Arnan; Sangwon Han
Journal:  Front Neurol       Date:  2014-10-27       Impact factor: 4.003

5.  Baseline Prescription and One-Year Persistence of Secondary Prevention Drugs after an index Stroke in Central Ghana.

Authors:  Fred Stephen Sarfo; Bruce Ovbiagele; John Akassi; Gloria Kyem
Journal:  eNeurologicalSci       Date:  2016-12-28

6.  Impact of Smoking Status on Stroke Recurrence.

Authors:  Jingjing Chen; Shun Li; Kuo Zheng; Huaiming Wang; Yi Xie; Pengfei Xu; Zhengze Dai; Mengmeng Gu; Yaqian Xia; Min Zhao; Xinfeng Liu; Gelin Xu
Journal:  J Am Heart Assoc       Date:  2019-04-16       Impact factor: 5.501

7.  Antihypertensive medication persistence 1-year post-stroke hospitalization.

Authors:  Andrea D Boan; Brent M Egan; David L Bachman; Robert J Adams; Wuwei Wayne Feng; Edward C Jauch; Bruce Ovbiagele; Daniel T Lackland
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-10-13       Impact factor: 3.738

8.  Stroke Minimization through Additive Anti-atherosclerotic Agents in Routine Treatment (SMAART): study protocol for a randomized controlled trial.

Authors:  Fred Stephen Sarfo; Osei Sarfo-Kantanka; Sheila Adamu; Vida Obese; Jennifer Voeks; Raelle Tagge; Vipin Sethi; Bruce Ovbiagele
Journal:  Trials       Date:  2018-03-14       Impact factor: 2.279
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.